Removing IL-10 in co-cultures of monocytes and tumor cells can reduce the upregulation of PD-L1 in monocytes and affect the curative effect of the immune checkpoint inhibitors (Wang et al., 2017). The gene discussed is IL10; the disease is neoplasm.